1. Sub-Segment: Ventricular Assist Devices (VAD)
Ventricular Assist Devices (VAD) are implantable mechanical pumps that are used to support and augment the pumping function of the heart's ventricles. These devices are commonly used as a bridge to transplant, providing support for patients awaiting heart transplantation. The increasing prevalence of heart failure and the shortage of suitable donor hearts have led to the growing adoption of VADs.
2. Sub-Segment: Total Artificial Heart
A total artificial heart is a mechanical device that replaces both diseased ventricles of the heart, providing circulatory support. It is primarily used as a bridge to transplant for patients with end-stage heart failure. The demand for total artificial hearts is increasing due to advancements in technology, improved survivability rates, and limited availability of donor hearts for transplantation.
The heart pump devices market is highly competitive, with several key players operating globally. Some of the leading market players include:
1. Abbott Laboratories
2. Medtronic plc
3. Terumo Corporation
4. SynCardia Systems, LLC
5. Berlin Heart GmbH
6. Abiomed, Inc.
7. Jarvik Heart, Inc.
8. CardiacAssist, Inc.
9. ReliantHeart Inc.
10. Leviticus Cardio Ltd.
These market players focus on strategies like mergers and acquisitions, collaborations, and product innovations to maintain their market position and gain a competitive edge. The market is characterized by intense competition, technological advancements, and a continuous focus on research and development activities to develop more efficient and advanced heart pump devices.